![]() |
市场调查报告书
商品编码
1883004
异地灭菌服务市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032)Off-Site Sterilization Services Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
预计2024年全球异地灭菌服务市场规模将达22.2亿美元,2025年将达22.9亿美元,到2032年将进一步成长至30.1亿美元。北美地区将在2024年以39.63%的市场占有率引领市场,这主要得益于其先进的医疗基础设施、较高的住院率以及医院获得性感染(HAI)的上升趋势。
异地灭菌是指将医疗和製药设备运送到专门的设施进行灭菌,然后再将其送回医疗机构的过程。这可以确保设备安全并符合卫生标准。由于其高效、经济且能够满足全球日益增长的手术和住院需求,这种模式正被越来越多地采用。包括 STERIS、Sterigenics U.S., LLC(Sotera Health)和 Medistri SA 在内的市场主要参与者正在扩展其服务能力,以满足不断增长的需求。
市场驱动因素
全球住院和手术数量的不断增长是推动市场成长的主要因素。心血管疾病和妇科疾病等慢性病患者人数的增加,使得医疗设备需要频繁消毒。例如,美国医院协会 (AHA) 报告称,到 2023 年,美国住院患者人数将达到约 3,440 万人。此外,人口老化也导致手术数量增加,进一步推动了对院外消毒服务的需求。
医院感染 (HAI) 的增加也推动了外包服务的普及,以维持感染控制标准。外包灭菌操作可以降低污染风险,同时确保符合严格的医疗保健法规。先进的灭菌技术,例如电子束 (E-beam) 灭菌和气化过氧化氢 (VHP) 灭菌,为传统方法提供了更快、更有效率、更安全的替代方案,从而促进了其广泛应用。
市场限制因子
儘管有这些优势,但成本问题可能会限制市场成长。异地灭菌会产生运输成本、潜在的设备损坏风险,并且需要完善的品质控制和沟通系统。医疗预算有限的国家的医疗机构可能难以实施此类服务。此外,关于传染性材料运输的严格法规增加了服务提供者的合规复杂性和营运成本。
市场机会
服务提供者与医疗机构之间的策略联盟蕴藏着巨大的机会。透过合作、併购,企业能够拓展地域覆盖范围,并提供先进的灭菌技术,例如蒸汽灭菌、环氧乙烷 (EO) 灭菌和过氧化氢 (VHP) 灭菌。製药业的扩张以及医院、诊所和门诊手术中心的兴起,正在推动对高品质异地灭菌服务的需求。
市场趋势
一个关键趋势是先进灭菌技术的整合。电子束灭菌利用高能量电子束对医疗器材进行灭菌,无需使用化学品,因其高效、快速和永续性而日益普及。自动化技术(例如自动参数调节、自动装卸和条码追踪)提高了营运效率和合规性。例如,2024 年 12 月,BGS 在其美国工厂安装了一台高功率电子束加速器,这表明该行业对先进技术的采用率正在不断提高。
依服务类型划分,合约灭菌服务将在 2024 年占主导地位,这反映了医疗器材製造商倾向于将灭菌流程外包。验证服务虽然在 2024 年规模较小,但由于监管合规要求,预计将会成长。
依灭菌方法划分,蒸气灭菌因其成本效益和可靠性,在 2024 年引领市场。过氧化氢和环氧乙烷灭菌方法正在扩展,为精密器械提供可扩展的专业灭菌解决方案。
依最终用户划分,由于医院感染 (HAI) 的高发生率和频繁的外科手术,医院和诊所是 2024 年的主要需求来源。製药和医疗器材製造商是第二大区隔市场,推动了对合约灭菌和先进技术整合的需求。
预计北美将在2024年以8.8亿美元的市场规模引领市场,主要得益于高手术量和对灭菌基础设施的投资。欧洲位居第二,这主要得益于其专注于医疗机构的灭菌业务外包。亚太地区预计将在预测期内实现最高成长,这主要得益于药品生产的扩张、医疗设施的现代化以及灭菌技术的日益普及。拉丁美洲和中东及非洲是新兴市场,其监管架构和医疗基础设施正在不断改善。
The global off-site sterilization services market was valued at USD 2.22 billion in 2024 and is projected to reach USD 2.29 billion in 2025, growing further to USD 3.01 billion by 2032. North America dominated the market in 2024 with a 39.63% share, driven by advanced healthcare infrastructure, a high number of hospital admissions, and the increasing prevalence of hospital-acquired infections (HAIs).
Off-site sterilization involves transporting medical and pharmaceutical instruments to specialized facilities for sterilization, ensuring equipment safety and compliance with hygiene standards before returning them to healthcare facilities. This model is increasingly preferred due to its efficiency, cost-effectiveness, and ability to handle the rising number of surgeries and patient admissions worldwide. Major companies operating in the market include STERIS, Sterigenics U.S., LLC (Sotera Health), and Medistri SA, which are expanding their service capabilities to meet growing demand.
Market Drivers
The market is primarily driven by the increasing number of hospital admissions and surgical procedures globally. Chronic conditions, such as cardiovascular diseases and gynecological disorders, have increased patient load, necessitating frequent sterilization of medical instruments. For example, the American Hospital Association (AHA) reported approximately 34.4 million hospital admissions in the U.S. in 2023. Additionally, the aging population is contributing to a higher incidence of surgeries, further driving demand for off-site sterilization services.
Rising cases of HAIs also promote the adoption of off-site services to maintain infection control standards. Outsourcing sterilization reduces the risk of contamination while ensuring compliance with stringent healthcare regulations. Advanced sterilization technologies, such as electron beam (E-beam) sterilization and vaporized hydrogen peroxide (VHP), offer faster, more efficient, and safer alternatives to conventional methods, enhancing adoption.
Market Restraints
Despite the benefits, cost concerns may limit market growth. Off-site sterilization incurs transportation expenses, potential equipment damage costs, and requires robust quality control and communication systems. Healthcare facilities in countries with limited healthcare budgets may find it challenging to adopt such services. Additionally, strict regulations for transporting potentially infectious materials add compliance complexities, increasing operational costs for service providers.
Market Opportunities
Strategic collaborations between service providers and healthcare facilities present significant opportunities. Partnerships, mergers, and acquisitions enable companies to expand regional coverage and offer advanced sterilization technologies, including steam sterilization, ethylene oxide (EO), and VHP sterilization. Expanding pharmaceutical manufacturing and the growing number of hospitals, clinics, and ambulatory surgery centers drive demand for high-quality off-site sterilization services.
Market Trends
A key trend is the integration of advanced sterilization technologies. Electron beam sterilization, which uses high-energy electrons to sterilize medical devices without chemicals, is gaining popularity due to efficiency, speed, and sustainability. Automation technologies, including self-adjusting parameters, automated loading/unloading, and barcode tracking, improve operational efficiency and regulatory compliance. For instance, in December 2024, BGS installed a high-power E-beam accelerator at its U.S. facility, highlighting industry adoption of advanced technologies.
By service type, contract sterilization services dominated in 2024, reflecting the preference of medical device manufacturers for outsourcing sterilization. Validation services, while smaller in 2024, are expected to grow due to regulatory compliance requirements.
By method, steam sterilization led the market in 2024, appreciated for cost-effectiveness and reliability. Hydrogen peroxide and ethylene oxide methods are expanding, offering scalable and specialized sterilization solutions for sensitive instruments.
By end-user, hospitals and clinics dominated in 2024 due to the high prevalence of HAIs and frequent surgical procedures. Pharmaceutical and medical device manufacturers form the second-largest segment, driving demand for contract sterilization and advanced technology integration.
North America led the market in 2024 with a market size of USD 0.88 billion, driven by high surgical volumes and investment in sterilization infrastructure. Europe ranked second, focusing on outsourcing sterilization in healthcare settings. Asia Pacific is expected to witness the highest growth during the forecast period, supported by expanding pharmaceutical production, modernized healthcare facilities, and increasing adoption of sterilization technologies. Latin America and the Middle East & Africa are emerging markets, where regulatory frameworks and healthcare infrastructure are improving.
Competitive Landscape and Key Developments
Key players, including STERIS, Sterigenics U.S., LLC, and Medistri SA, focus on expanding facilities, partnerships, and technological capabilities. Notable recent developments include STERIS constructing a new EO processing facility in Malaysia in May 2025 and Sterigenics U.S., LLC opening a state-of-the-art X-ray sterilization facility in North Carolina in May 2025. These expansions aim to meet rising demand for advanced sterilization services globally.
Conclusion
The off-site sterilization services market, valued at USD 2.22 billion in 2024, USD 2.29 billion in 2025, and projected to reach USD 3.01 billion by 2032, is poised for steady growth. Increasing hospital admissions, rising HAIs, advanced sterilization technologies, and strategic collaborations are driving market expansion, while cost and regulatory challenges remain key considerations. North America leads in market share, with Asia Pacific emerging as the fastest-growing region.
Segmentation By Service Type
By Method
By End-user
By Region